Skip to content

Effective stimulation duration by nGVS

The Effective Stimulation Duration in Improving Balance with noisy galvanic vestibular stimulation

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042240042
Enrollment
20
Registered
2024-06-12
Start date
2024-08-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular disease dizziness

Interventions

noisy galvanic vestibular stimulation (nGVS)
E02-600-20

Sponsors

Iwasaki Shinichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Between the ages of 60 and 84 2. Healthy people without dizziness, hearing loss, and ear diseases 3. Written informed consent

Exclusion criteria

Exclusion criteria: 1. with metal in the body, such as cerebral artery clips or pacemakers 2. orthopedic conditions (especially acute painful conditions such as fractures, sprains, and separated flesh) 3. with heart disease 4. unable to walk independently 5. malignant tumor 6. sensory disturbance due to severe peripheral circulatory disturbance caused by diabetes mellitus, etc. 7. skin abnormality (infection, wound, etc.) at the electrode application site, or skin allergy to surface electrodes 8. taking tranquilizers or antidepressants 9. Those who drank alcohol after 10:00 p.m. on the day before the examination 10. other patients who are judged to be inappropriate as subjects 11. Those who may have conflicts of interest such as relatives of the principal investigator and collaborators of this study.

Design outcomes

Primary

MeasureTime frame
Comparison of the Normalized Ratio of the total length of the posturography immediately after the stimulation of nGVS

Secondary

MeasureTime frame
(1) Comparison of the Normalized Ratio (NR) of the area and RMS of the posturography immediately after the stimulation of nGVS (2) Comparison of the NR of the total length, area, and RMS of the posturography, during and immediately after 30 minutes of stimulation of nGVS. (3) Comparison of the NR of the total length, area, and RMS of the posturography, during and immediately after 1 hour of stimulation of nGVS. (4) Comparison of the NR of the total length, area, and RMS of the posturography, at 30 minitus, 1 hour, and 3 hours after the end of stimulation of nGVS. (5) Adverse events

Contacts

Public ContactKAYOKO KABAYA

Nagoya City University Hospital

kabaya@med.nagoya-cu.ac.jp+81-528538256

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026